Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 15.59
+1.07 (7.37%)
At close: Feb 13, 2026
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 16.44 billion as of February 13, 2026. Its market cap has decreased by -27.38% in one year.
Market Cap
16.44B
Enterprise Value
12.55B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.59
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 16.44B, an increase of 1,110.19%. That is a compound annual growth rate of 34.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 16.67B | 9.18% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 28.41B |
| Genscript Biotech | 27.94B |
| InnoCare Pharma | 25.54B |
| Ascentage Pharma Group International | 17.53B |
| Keymed Biosciences | 17.47B |
| Ascletis Pharma | 17.00B |
| Everest Medicines | 13.91B |
| Nanjing Leads Biolabs | 12.66B |